A phase I dose escalation study of topical bexarotene in women at high risk for breast cancer

被引：0
|
作者：
Thomas, P. S.
Patel, A. B.
Contreras, A.
Liu, D. D.
Lee, J. J.
Khan, S.
Vornik, L. A.
Dimond, E. P.
Perloff, M.
Heckman-Stoddard, B. M.
Brown, P. H.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-OT2-09-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-09-02
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
    Thomas, Parijatham S.
    Patel, Anisha B.
    Lee, J. Jack
    Liu, Diane D.
    Hernandez, Mike
    Muzzio, Miguel
    Contreras, Alejandro
    Sepeda, Valerie
    Mays, Carrie
    Weber, Diane
    Vornik, Lana A.
    Khan, Seema A.
    Dimond, Eileen
    Heckman-Stoddard, Brandy M.
    Perloff, Marjorie
    Brown, Powel H.
    CANCER PREVENTION RESEARCH, 2023, 16 (01) : 47 - 56
  • [2] Interim analysis of a phase I dose escalation study of topical bexarotene in women at high risk for breast cancer
    Thomas, Parijatham S.
    Patel, Anisha B.
    Liu, Diane
    Lee, J. Jack
    Khan, Seema
    Muzzio, Miguel
    Contreras, Alejandro
    Vornik, Lana
    Dimond, Eileen P.
    Perloff, Marjorie
    Heckman-Stoddard, Brandy
    Brown, Powel H.
    CANCER RESEARCH, 2021, 81 (04)
  • [3] Phase I Dose Escalation Study of Pirarubicin in Combination with Cyclophosphamide in Breast Cancer
    Sakata, M.
    Jinno, H.
    Hayashida, T.
    Takahashi, M.
    Sato, T.
    Seki, H.
    Shimada, K.
    Nishiya, S.
    Kitagawa, Y.
    CANCER RESEARCH, 2010, 70
  • [4] A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
    Welch, John S.
    Niu, Haixia
    Uy, Geoffrey L.
    Westervelt, Peter
    Abboud, Camille N.
    Vij, Ravi
    Stockerl-Goldstein, Keith E.
    Jacoby, Meagan
    Pusic, Iskra
    Schroeder, Mark A.
    Dipersio, John F.
    Cashen, Amanda F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) : E103 - E108
  • [5] Acquisition of breast tissue in a biomarker modulation study using bexarotene in women at high risk of breast cancer.
    Arun, B
    Mohsin, S
    Miller, A
    Isaacs, C
    Saxton, K
    Hilsenbeck, S
    Lamph, W
    Johnson, K
    Brown, P
    Elledge, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 106S - 106S
  • [6] PROGRESSIVE DOSE ESCALATION OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER - A PHASE-I STUDY
    BLACK, G
    PAVY, MD
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 347 - 347
  • [7] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    T Sakiyama
    J Tsurutani
    T Iwasa
    H Kawakami
    Y Nonagase
    T Yoshida
    K Tanaka
    Y Fujisaka
    T Kurata
    Y Komoike
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2015, 112 : 819 - 824
  • [8] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    Sakiyama, T.
    Tsurutani, J.
    Iwasa, T.
    Kawakami, H.
    Nonagase, Y.
    Yoshida, T.
    Tanaka, K.
    Fujisaka, Y.
    Kurata, T.
    Komoike, Y.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 819 - 824
  • [9] A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients
    Zhou, Xinna
    Yu, Jing
    Wang, Wenmiao
    Song, Guohong
    Wang, Xiaoli
    Ren, Jun
    Di, Lijun
    Wang, Xinghe
    SPRINGERPLUS, 2015, 4 : 1 - 6
  • [10] A PHASE-I HIGH-DOSE ESCALATION STUDY OF CARBOPLATIN
    GORE, M
    CALVERT, AH
    SMITH, IE
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 60 - 60
12345